Disease/Infection News

RSS

Superior T-cell immunity in COVID vaccinated

A recent study published in the journal Public Library of Science (PLOS) ONE presented the T cell and humoral immune responses following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection against the SARS-CoV-2 original and mutant strains.

27 Apr 2022

Fourth dose of COVID vaccine in over 60 years significantly effective

In a recent study published in the Nature Medicine journal, the researchers assessed the effectiveness of a second booster dose of the BioNTech, Pfizer BNT162b2 vaccine against coronavirus disease 2019 (COVID-19) severity in elderly patients.

26 Apr 2022

Asymptomatic SARS-CoV-2 infection among research personnel: Study

A recent research paper published in the journal Public Library of Science (PLOS) ONE analyzed asymptomatic coronavirus disease 2019 (COVID-19) in personnel engaged in academic study.

26 Apr 2022

Well-established group of antimalarials unlikely to be affected by resistance, study shows

New research published today in Antimicrobial Agents and Chemotherapy, shows that the well-established group of antimalarials, known as artemisinins, are unlikely to be affected by resistance.

26 Apr 2022

Antibodies against the original strain of SARS-CoV-2 may not work as well with omicron

If you're wondering why after two vaccination doses and a booster shot, you still got sick from the omicron strain of the virus that causes COVID-19, one possible answer may have been found in a recent study by researchers at Johns Hopkins Medicine and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

26 Apr 2022

Omicron caused an increase in COVID-19 cases in pregnant women, but less severe illness

Women who were pregnant during the recent Omicron surge were diagnosed with COVID-19 at a much higher rate than during previous phases of the pandemic, but were less likely to develop severe illness, a study by UT Southwestern and Parkland Health scientists found.

26 Apr 2022

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

A new study examined the protective effect of the mRNA booster vaccine against the SARS-CoV-2 Omicron variant in 21-month-old mice.

26 Apr 2022

Phase I/II trials of new paratyphoid vaccine begin in Oxford

The University of Oxford in collaboration with the University of Maryland School of Medicine has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford - with first vaccinations taking place today (Tuesday).

26 Apr 2022

Free fatty acid-binding pocket found to be preserved across spike proteins of beta coronaviruses

Researchers assessed the binding pocket of linoleic acid, an essential free-fatty acid in the receptor-binding domains of the spike protein of beta-coronaviruses.

26 Apr 2022

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Researchers developed a highly pathogenic mouse-adapted SARS-CoV-2 strain to model mild, moderate, or COVID-19.

26 Apr 2022

Evidence of increased intrinsic cleavability of SARS-CoV-2 Omicron spike protein by host cell furin

Researchers conducted an in vitro analysis to assess the host cell furin-mediated cleavability of the spike protein of the SARS-CoV-2 Omicron (B.1.529) variant.

26 Apr 2022

Characteristics of viral infection super-spreaders

Researchers evaluated whether certain super-spreaders transmit viral infection better and the impacts of individual variance in epidemiological characteristics.

26 Apr 2022

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Researchers identified a nanobody inhibiting SARS-CoV-2 variants.

26 Apr 2022

Clinical traits with inflammation characterization of long COVID and correlation with one-year recovery after COVID-19-linked hospitalization

Researchers presented the clinical traits with inflammation characterization of long COVID and correlation with one-year recovery after COVID-19-linked hospitalization.

26 Apr 2022

Disease/Infection News

Superior T-cell immunity in COVID vaccinated

Fourth dose of COVID vaccine in over 60 years significantly effective

Asymptomatic SARS-CoV-2 infection among research personnel: Study

Well-established group of antimalarials unlikely to be affected by resistance, study shows

Antibodies against the original strain of SARS-CoV-2 may not work as well with omicron

Omicron caused an increase in COVID-19 cases in pregnant women, but less severe illness

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

Phase I/II trials of new paratyphoid vaccine begin in Oxford

Free fatty acid-binding pocket found to be preserved across spike proteins of beta coronaviruses

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Evidence of increased intrinsic cleavability of SARS-CoV-2 Omicron spike protein by host cell furin

Characteristics of viral infection super-spreaders

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Clinical traits with inflammation characterization of long COVID and correlation with one-year recovery after COVID-19-linked hospitalization

Study explores SARS-CoV-2 antibody responses in mild COVID-19 cases

Eradicating Polio; What's it going to take?

The response of four SARS-CoV-2 spike variants to linoleic acid removal

Quantum dot biomimetic for SARS-CoV-2 examines neurovascular dysregulation related to brain inflammation

Effectiveness of CoronaVac, AZD1222, and BNT162b2 vaccine boosters

The impact of leronlimab on CCR5 surface cell levels during long COVID

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News